SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Alto Ingredients, Inc. (ALTO) (CIK 0000778164) (ALTO) — Jan 28, 2020

Alto Ingredients, Inc. (ALTO) (CIK 0000778164)
Date: Jan. 28, 2020 · CIK: 0000778164 · Accession: 0000000000-20-000731

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-235990

Date
January 27, 2020
Author
Neil M. Koehler
Form
UPLOAD
Company
Alto Ingredients, Inc. (ALTO) (CIK 0000778164)

Letter

January 27, 2020 Neil M. Koehler Chief Executive Officer Pacific Ethanol, Inc. 400 Capitol Mall, Suite 2060 Sacramento, CA 95814 Re:Pacific Ethanol, Inc. Registration Statement on Form S-1 Filed January 21, 2020 File No. 333-235990 Dear Mr. Koehler: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Larry A. Cerutti, Esq.

Show Raw Text
January 27, 2020
Neil M. Koehler
Chief Executive Officer
Pacific Ethanol, Inc.
400 Capitol Mall, Suite 2060
Sacramento, CA 95814
Re:Pacific Ethanol, Inc.
Registration Statement on Form S-1
Filed January 21, 2020
File No. 333-235990
Dear Mr. Koehler:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Larry A. Cerutti, Esq.